His scientific interests lie mostly in Internal medicine, Surgery, Gastroenterology, Kidney disease and Transplantation. His biological study spans a wide range of topics, including Endocrinology and Nephropathy. His Nephropathy research is multidisciplinary, incorporating perspectives in Pregnancy, Biopsy, Immunology and Obstetrics.
His Gastroenterology research incorporates themes from Glomerulonephritis, Glomerulosclerosis, Pathology, Renal biopsy and Rituximab. His work carried out in the field of Kidney disease brings together such families of science as Lupus nephritis, Kidney and Pharmacology. His Transplantation research includes elements of Stroke, Diabetes mellitus and Urology.
His primary scientific interests are in Internal medicine, Surgery, Gastroenterology, Transplantation and Immunology. Internal medicine is often connected to Endocrinology in his work. His studies in Surgery integrate themes in fields like Azathioprine, Kidney disease and Urology.
Within one scientific family, he focuses on topics pertaining to Renal function under Urology, and may sometimes address concerns connected to Creatinine. As a part of the same scientific study, he usually deals with the Gastroenterology, concentrating on Lupus nephritis and frequently concerns with Lupus erythematosus. Claudio Ponticelli interconnects Immunosuppression, Kidney and Everolimus in the investigation of issues within Transplantation.
Claudio Ponticelli mostly deals with Internal medicine, Immunology, Kidney transplantation, Membranous nephropathy and Pathology. His research in Internal medicine intersects with topics in Gastroenterology and Rituximab. The various areas that he examines in his Immunology study include Glomerulonephritis and Nephropathy.
Claudio Ponticelli has researched Kidney transplantation in several fields, including Renin–angiotensin system, Dialysis, Bioinformatics and Intensive care medicine. His research on Pathology also deals with topics like
His main research concerns Immunology, Kidney transplantation, Transplantation, Internal medicine and Pathology. His work deals with themes such as Genome-wide association study, Nephropathy and Membranous nephropathy, which intersect with Immunology. His Kidney transplantation research integrates issues from Adverse effect, Risk of mortality and Calcineurin.
His Transplantation study necessitates a more in-depth grasp of Surgery. The study incorporates disciplines such as Gastroenterology and Endocrinology in addition to Internal medicine. His study in Pathology is interdisciplinary in nature, drawing from both Kidney and Glomerular basement membrane.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
Giuseppe Maschio;Daniele Alberti;Gérard Janin;Francesco Locatelli.
The New England Journal of Medicine (1996)
Corticosteroids in IgA nephropathy: a randomised controlled trial
Claudio Pozzi;PierGiorgio Bolasco;GianBattista Fogazzi;Simeone Andrulli.
The Lancet (1999)
Corticosteroid Effectiveness in IgA Nephropathy: Long-Term Results of a Randomized, Controlled Trial
Claudio Pozzi;Simeone Andrulli;Lucia Del Vecchio;Patrizia Melis.
Journal of The American Society of Nephrology (2004)
Genome-wide association study identifies susceptibility loci for IgA nephropathy
Ali G Gharavi;Krzysztof Kiryluk;Murim Choi;Yifu Li.
Nature Genetics (2011)
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens
Krzysztof Kiryluk;Yifu Li;Francesco Scolari;Simone Sanna-Cherchi.
Nature Genetics (2014)
A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy
Claudio Ponticelli;Pietro Zucchelli;Patrizia Passerini;Bruno Cesana.
Kidney International (1995)
A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
Claudio Ponticelli;Paolo Altieri;Francesco Scolari;Patrizia Passerini.
Journal of The American Society of Nephrology (1998)
Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.
S Casati;P Passerini;M R Campise;G Graziani.
IMPROVEMENT IN THE HAEMOSTATIC DEFECT OF URAEMIA AFTER TREATMENT WITH RECOMBINANT HUMAN ERYTHROPOIETIN
Marco Moia;Laura Vizzotto;Marco Cattaneo;Pier Mannuccio Mannucci.
The Lancet (1987)
A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome
Claudio Ponticelli;Gianfranco Rizzoni;Alberto Edefonti;Paolo Altieri.
Kidney International (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: